Exam 4 Flashcards
Sympathetic system
Two neurons
Short then long ganglion
Postganglion release NE and E
The sympathetic trunk ganglia innervates what
Thorax, abdomen, head, neck
The prevertebral ganglia innervates what
Organ below diaphragm
What is the percentage release of E and NE in sympathetic system and adrenal medulla
Sympathetic: 80% NE, 20% E
Adrenal Medulla: 20% NE, 80% E
What happens in the adrenal medulla
One neuron system
ACh is released by pregnaglion
Preganglion innervates chromaffin cells in medulla and release NE and E
(NE and E are hormones because they are in the circulation and not released at a synapse)
What are the presynaptic receptors in the sympathetic system and adrenal medulla
Both are nicotinic receptors (Nn)
For the adrenergic presynaptic receptors what do the auto receptors and hetero receptors do in respect to NE release
Auto receptors: inhibit and activate NE release
Hetero receptors: inhibit NE release
What are the two subgroups of the adrenergic receptors
Alpha and Beta
What does a2 receptor do
autoreceptor that inhibits of NE release
What does b2 receptor do
autoreceptor that facilitates of NE release
Heteroreceptors presynaptically
inhibit release of NE (M2, M4)
-DA receptor
-Histamine receptor
-Serotonin receptor
What is a1 receptor
Gq, PLC, increase IP3 DAG and Ca2+
What is a2 receptor
Gi, AC, decrease cAMP
What is b1, b2, and b3 receptor
Gs, AC, increase cAMP
E and NE in a1, a2, b1, b2, b3
a1: E > NE
a2: E = NE
b1: E = NE
b2: E > NE
b3: E < NE
Catecholamines
Involved in chemical transmission in the CNS and PNS
Dopamine (mesocortical neuron) -> NE (sympathetic postganglionic neurons) -> E (adrenal medulla)
Synthesis of catecholamines
hydroxylation -> decarboxylation -> hydroxylation -> methylation
Enzyme locations of catecholamines
DBM in secretory vesicles
Enzymes and primary product of dopaminergic neurons
Product: Dopamine
Little or no DBM and PNMT
Enzymes and primary product of adrenergic neurons
product: NE
Less PNMT than DBM
Enzymes and primary product of adrenal medulla
E (80%) NE (20%)
DBM and PNMT present
What drugs inhibit CA synthesis
alpha-methyltyrosine (inhibit tyrosine hydroxylase, treat pheochromocytoma)
carbidopa (increases DOPA, treatment of parkinsonism)
What drugs inhibit CA storage
reserpine (inhibit VMAT, antihypertensive drug)
tetrabenazine (inhibit VMAT, hyperkinetic disorders)
Inhibitor effects of VMAT mechanism
decrease NE storage -> decrease NE release
depletion of CA at synapse
NE accumulated in cytoplasm is degraded
Diffusion of CA (catecholamine action) at synapse
Dilution of CA at synapse
Uptake at extraneuronal sites by non-neuronal transporters
Reuptake of CA (catecholamine action) at synapse
(85% of CA)
Into nerve terminals by neuronal transporters
CA can be stored in vesicles and/or metabolized
Metabolism of CA (catecholamine action) at synapse
Following uptake and reuptake, CA undergoes enzymatic catabolism
Reuptake of CA: Neuronal and Non-Neuronal transporters
Neuronal:
-Norepinephrine transporter (NET) –neurons, adrenal medulla, liver, placenta
-Dopamine transporter (DAT) –neurons, kidney, stomach, pancreas
Non-neuronal:
-OCT1, OCT2, ENT –liver, kidney, intestine
NET affinity and DAT affinity
NET: NE > E and DA
DAT: DA > NE and E
DAT and NET transporters
block antidepressants and substance of abuse
increase NT levels at synapse
NET - Cocaine, Desipramine
DAT - Cocaine, Mazindol
NET transporter movement of molecules
Co-transporter (symport) Na+, Cl-, NE
Na+ and energy dependent, Na/K ATPase creates Na+ gradient
Binding of K+ returns the transporter to outward position
What are MAO (monoamine oxidase)
MAO-A
-Periphery: placenta and liver
-Brain: region containing catecholamines
-NE, E, DA, serotonin
MAO-B
-Periphery: platelets, lymphocytes, liver
-Brain
-DA, amines
What are COMT (catechol-O-methyl-transferase)
Largely cytoplasmic enzyme
Exception in adrenal medulla is membrane bound
Less COMT than MAO in sympathetic neurons
Catabolism of NE and E: MAO mechanism
MAO forms aldehyde (DOPGAL) then turns into an alcohol (DOPEG)
Catabolism of NE and E: COMT mechanism
COMT methylates DOPEG to form MOPEG converted to VMA
What is the final end product of DA metabolism
HVA (homovanillic acid)
What is another route to form VMA other than COMT main pathway
minor pathway in neurons
methylation of NE and E by COMT then deamination by MAO, MOPGAL formed then VMA
Classification of adrenergic agonists
Adrenergic agonists:
Directing acting -> Selective and nonselective: act directly on one or more of the adrenergic receptors
Mixed-acting: indirectly release NE and activate receptors
Indirect acting -> Releasing agents, uptake inhibitor, MOA inhibitor, COMT inhibitors: increase NE or E levels to stimulate adrenergic receptors
Adrenergic Effects in the eye
Dilation of pupils (mydriasis)
Far vision: muscle relaxation, increase ligament tension, flat lens
Adrenergic receptors: Iris dilator
radial muscle only sympathetic innervation
pupil dilation
Adrenergic receptors: Ciliary muscle
also parasympathetic innervation M3R
far vision (flat lens)
a1 adrenergic receptors in the eye
Gq
increase Ca2+
Muscle contraction
B2 receptors in the eye
Gs
Increase cAMP
myosin light chain kinase-P (inactive)
Muscle relaxation
Difference between radial muscle and circular muscle
radial muscle: pull out, dilation
circular muscle: muscle relaxation, decrease pupil size
Adrenergic effects on the respiratory tract
Bronchodilation: relax bronchial smooth muscle, decrease airway resistance
Decrease bronchial secretion
What kind of receptors do bronchi have
B2 receptors -> E has a better effect than NE
Short-acting beta 2 adrenergic agonists
Albuterol (salbutamol)
Levalbuterol (xopenex)
sulfation metabolism
Systemic SABA beta 2 adrenergic agonists
Terbutaline (brethine)
Epinephrine
sulfation metabolism
Long Acting beta 2 adrenergic agonists
Formoterol (foradil)
Salmeterol (serevent)
COMT and MAO metabolism
Very long acting beta 2 adrenergic agonists
Indacaterol (arcapta neohaler)
Arformoterol (brovana)
Olodaterol (striverdi, resoimat)
Vilanterol only in combination inhalers
Glucuronidation and O-demethylation
Mechanism of action of smooth muscle contraction
Increase intracellular Ca2+
bind to calmodulin (CaM)
activates myosin light chain kinase (MLCK)
Increase myosin ATPase activity
cross bridges slide along actin and create muscle tension
Combination inhalors
Contain long-acting inhaled B2 agonist & corticosteroid
Advair: Salmeterol and fluticasone
Symbicort: Formoterol and budesonide
Dulera: Formoterol and nometasone
Brea Ellipta: Vilanterol and fluticasone
Adverse effect die to excessive activation of B2 receptors
Muscle tremor (skeletal muscle)
Tachycardia: due to reflex effect, vasodilation, stimulation of heart
Hypokalemia
Metabolic effects
Adrenergic effects in the heart
Increase heart rate (chronotropy)
Increase rate of conduction (dromotropy)
Increase force of contraction (inotropy)
Disturb cardiac rhythm and cause arrhythmias
What does the AV and SA node do
AV increase conduction velocity
SA increase heart rate
Cardiac therapeutic uses of beta agonists
Rapid on set short duration
E: cardiac arrest
Dobutamine: increase contractility -> used for cardiac surgery, heart failure, acute myocardial infarction
Blood vessels are only activated by what system
Sympathetic (increase system, increases vasoconstriction)
What are the receptors in the sympathetic vessels and what do they do
Alpha 1: contraction caused by baroreceptors
Beta 2: relaxation, increases blood flow
Alpha 1 adrenergic agonist drugs to treat hypotension
Metadaminol
Midodrine (prodrug)
Side effects are urine retention, goose bumps, bradycardia
Condone alpha 2 adrenergic agonist
Treats hypertension and opiate withdrawal
Diagnose hypertension and pheochromocytoma